Affinergy Inc.
This article was originally published in Start Up
Executive Summary
Affinergy has--patented and in the freezer--peptide binders that stick specifically to the common materials of which medical implants are made, for example, collagen, titanium and stainless steel. These are the starting point for the company's device coating platform. The other part of the biocoating, which attaches to the device-binding peptide by a linker, is a peptide that binds to a specific protein or cell type of interest to a partner.
You may also be interested in...
Biocoatings: Not Just the Icing on the Cake
The successful commercialization of drug-eluting stents (DES) has done much to pave the way for the biocoating industy. DES not only helped establish a new regulatory body to facilitate device-drug reviews, the FDA Office of Combination Products, they also proved that biocoated devices could take market share from uncoated products, command premium pricing and premium reimbursement.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.